Recital 3, Regulation (EU) 2021/1248

In forcesince 29 Jul 2021

Several international standards and guidelines on good distribution practice exist for medicinal products for human use [Good storage and distribution practices for medical products, In: WHO Expert Committee on Specifications for Pharmaceutical Preparations: fifty-fourth report. Geneva: World Health Organization; 2020: Annex 7 (WHO Technical Report Series, No 1025).] [Guide to good storage practices for pharmaceuticals. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations: thirty-seventh report. Geneva: World Health Organization; 2003: Annex 9 (WHO Technical Report Series, No 908).] [Model guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations: forty-fifth report. Geneva: World Health Organization; 2011: Annex 9 (WHO Technical Report Series, No 961).] [PIC/S Guide to good distribution practice for medicinal products, PIC/S, PE 011-1, 1.6.2014.]. At Union level, guidelines on good distribution practice have been adopted only in respect of medicinal products for human use [Guidelines of 5 November 2013 on Good Distribution Practice of medicinal products for human use (2013/C 343/01) (OJ C 343, 23.11.2013, p. 1).]. Corresponding measures in the veterinary domain should take into account the experience gained with the application of the current system under Directive 2001/83/EC of the European Parliament and of the Council [Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ L 311, 28.11.2001, p. 67).] in light of the similarities and potential differences between the requirements on good distribution practice for medicinal products for human use and for veterinary medicinal products.